| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.082 | 0.008 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |